Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
45 studies found for:    " January 13, 2013":" February 12, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" January 13, 2013":" February 12, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)
Condition: HIV Infection
Interventions: Behavioral: 3MV;   Behavioral: PCC;   Drug: Emtricitabine/tenofovir (FTC/TDF (Truvada®))
2 Active, not recruiting
Has Results
Study to Evaluate the Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Positive, Antiretroviral Treatment-Naive Adults
Conditions: HIV;   HIV Infections
Interventions: Drug: E/C/F/TAF;   Drug: E/C/F/TDF;   Drug: E/C/F/TDF Placebo;   Drug: E/C/F/TAF Placebo
3 Completed Renal, Endocrine, and Bone Changes in Response to FTC/TDF in Uninfected Young Men Who Have Sex With Men (YMSM).
Condition: HIV Infection
Intervention: Drug: FTC/TDF (Truvada®)
4 Completed Feasibility of Using a Structured Daily Diary
Condition: HIV Infection
Intervention: Behavioral: Structured daily diary
5 Active, not recruiting Evaluating the Safety and Immune Response to Three HIV Vaccine Schedules in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: DNA-HIV-PT123 vaccine;   Biological: NYVAC-HIV-PT1 vaccine;   Biological: NYVAC-HIV-PT4 vaccine;   Biological: Placebo for DNA-HIV-PT123 vaccine;   Biological: Placebo for NYVAC-HIV-PT1 vaccine;   Biological: Placebo for NYVAC-HIV-PT4 vaccine
6 Enrolling by invitation IMPAACT P1092: Steady State PK in Malnourished HIV Infected Children
Conditions: HIV Positive;   Malnourished
Intervention: Drug: ZDV+3TC+LPV/r
7 Recruiting CVCTPlus: A Couples-Based Approach to Linkage to Care and ARV Adherence
Condition: HIV
Intervention: Behavioral: CVCTPLUS
8 Completed An Expanded Access Protocol for Subjects Who Have Completed Clinical Studies Involving Maraviroc
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Continued Access Arm
9 Recruiting Safety and Pharmacokinetics of Raltegravir in HIV-1-Exposed Newborn Infants at High Risk of Acquiring HIV-1 Infection
Condition: HIV Infections
Intervention: Drug: Raltegravir
10 Active, not recruiting Music for Health Project
Condition: Human Immunodeficiency Virus
Intervention: Behavioral: mobile phone application
11 Recruiting Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
Condition: HIV
Interventions: Behavioral: Suubi+Adherence;   Behavioral: Bolstered Standard of Care
12 Active, not recruiting Living Well Project for Persons With AIDS
Condition: Acquired Immunodeficiency Syndrome (AIDS)
Interventions: Behavioral: AIDS EPC Package plus MI;   Other: Standard of Care (SOC)
13 Recruiting Pediatric HIV Disclosure Intervention
Condition: Paediatric HIV Diagnosis Disclosure
Intervention: Behavioral: Cognitive behavioral intervention to support pediatric HIV disclosure
14 Recruiting DRV/r + RPV QD: Efficacy and Toxicity Reduction
Condition: Human Immunodeficiency Virus
Interventions: Drug: RPV + DRV/r;   Drug: continue the PI/r-containing HAART.
15 Completed Home-based Partner Education and Testing (HOPE) Study
Condition: HIV
Interventions: Behavioral: HOPE Intervention;   Behavioral: INVITE Intervention
16 Completed PK TDF in Thai HIV-infected Children
Condition: HIV
Interventions: Drug: TDF (Tenofovir);   Drug: Efavirenz;   Drug: lopinavir/ritonavir, atazanavir/ritonavir
17 Completed Switching Undetectables to Selzentry
Conditions: Human Immunodeficiency Virus;   AIDS
Intervention: Drug: Maraviroc
18 Completed Pilot Study of Bydureon to Treat Diabetes in HIV-infected Adults
Conditions: Human Immunodeficiency Virus Infection;   Diabetes Mellitus
Intervention: Drug: extended-release exenatide
19 Active, not recruiting Reducing HIV Stigma for African American Women
Condition: HIV
Interventions: Behavioral: Unity Workshop;   Behavioral: Breast Cancer Screening
20 Recruiting Carolina Alcohol and Drug Resources
Condition: HIV
Intervention: Behavioral: Comprehensive substance abuse services

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.